Results 141 to 150 of about 31,515 (266)

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America [PDF]

open access: yes, 2017
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America.
Andes, David   +13 more
core  

Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients [PDF]

open access: bronze, 2014
Gregory Eschenauer   +10 more
openalex   +1 more source

Antifungal Prophylaxis in Liver Transplant Recipients [PDF]

open access: yesClinical Infectious Diseases, 2015
Winston, Drew J   +2 more
openaire   +4 more sources

Toxicity of essential oils from Nordic plants against different pathogenic organisms and pests of cultivated plants

open access: yesAnnals of Applied Biology, Volume 188, Issue 1, Page 160-169, January 2026.
Plant essential oils (EOs) represent a potentially effective, safe, and eco‐friendly alternative to synthetic pesticides that cause negative effects for human health and the environment. The present study evaluated in airtight glass chambers the toxicity of vapours produced by EOs obtained from sweet gale, balsam poplar, Labrador tea, jack pine, and ...
Antoine Roy‐Lemieux   +4 more
wiley   +1 more source

Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient. [PDF]

open access: yes, 1994
Anonymous   +18 more
core   +1 more source

Oral nystatin versus intravenous fluconazole as neonatal antifungal prophylaxis: Non-inferiority trial

open access: hybrid, 2013
Ali Mersal   +8 more
openalex   +1 more source

Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 2, Page 222-230, January 2026.
Between 2012 and 2021 in France, invasive fungal diseases affected 1 in 50 patients with alcohol‐related hepatitis and at least two hepatic or extrahepatic complications, with substantially higher mortality than bacterial pneumonia. These findings support targeted screening and early antifungal strategies in this population, as currently recommended ...
Charlotte Mouliade   +9 more
wiley   +1 more source

Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031) [PDF]

open access: yes, 2017
In a prospective cohort study of 145 030 admissions of cancer patients from 13 European Organisation for Research and Treatment of Cancer centers fungemia occurred in 0.23%. Candida albicans was the predominant pathogen.
Akan, H.   +38 more
core  

Caspofungin as secondary antifungal prophylaxis and subsequent maintenance antifungal prophylaxis therapy in hematological malignancy patients.

open access: yesInternational journal of clinical and experimental medicine, 2015
This study aimed to investigate the efficacy and safety of caspofungin as secondary antifungal prophylaxis (SAP) and subsequent maintenance therapy for SAP in hematological malignancy patients.Forty four patients receiving caspofungin for SAP and 43 patients not receiving any SAP agents during their subsequent chemotherapy or HSCT were reviewed ...
Mingjuan, Liu   +12 more
openaire   +1 more source

Home - About - Disclaimer - Privacy